Evidence map›Paper›PMID 34133962›Full record

Observational studyDiabetes research and clinical practice2021

Laparoscopic bariatric surgery is safe during phase 2-3 of COVID-19 pandemic in Italy: A multicenter, prospective, observational study.

Gianfranco Silecchia, Cristian E Boru, Giuseppe M Marinari, Paolo Gentileschi, Mario Morino, Stefano Olmi, Mirto Foletto, Paolo Bernante, Riccardo Morganti, Carlo Tascini and 10 more

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Diabetes research and clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Gianfranco SilecchiaDivision of General Surgery and Bariatric Center of Excellence IFSO-EC, Department of Medico-Surgical Sciences and Biotechnologies, University "La Sapienza" of Rome, Via Corso della Repubblica 79, Latina, LT 04100, Italy. Electronic address: gianfranco.silecchia@uniroma1.it.
Cristian E BoruDivision of General Surgery and Bariatric Center of Excellence IFSO-EC, Department of Medico-Surgical Sciences and Biotechnologies, University "La Sapienza" of Rome, Via Corso della Repubblica 79, Latina, LT 04100, Italy. Electronic address: cristian.boru@uniroma1.it.
Giuseppe M MarinariBariatric Unit, Humanitas Clinical and Research Hospital, IRCCS Rozzano, Milan Via A. Manzoni 56, Rozzano, MI 20089, Italy. Electronic address: giuseppe.marinari@humanitas.it.
Paolo GentileschiDepartment of Bariatric and Metabolic Surgery, San Carlo of Nancy Hospital and "Tor Vergata" University of Rome, Via Aurelia 275, Roma, RM 00165, Italy. Electronic address: gentileschi.paolo@gmail.com.
Mario MorinoGeneral Surgery, Department of Surgical Sciences, University of Turin, Via Corso Bramante 88, Turin, TO 10126, Italy. Electronic address: mario.morino@unito.it.
Stefano OlmiDepartment of General and Oncological Surgery, Center of Bariatric Surgery, Policlinico San Marco di Zingonia, Bergamo Corso Europa 7, Zingonia, BG 24040, Italy. Electronic address: stefano.olmi@gmail.com.
Mirto FolettoBariatric Surgery Unit, Azienda Ospedaliera of University of Padova, Via Nicolò Giustiniani 2, Padova, PD 35128, Italy. Electronic address: mirto.foletto@unipd.it.
Paolo BernanteMetabolic and Obesity Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Centre for the Study and Research of Treatment for Morbid Obesity, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Via Giuseppe Massarenti 9, Bologna, BO 40138, Italy. Electronic address: paolo.bernante@aosp.bo.it.
Riccardo MorgantiSection of Statistics, University Hospital of Pisa, Via Roma, 67, Pisa, PI 56126, Italy. Electronic address: r.morganti@ao-pisa.toscana.it.
Carlo TasciniInfectious Diseases Clinic, DAME, University of Udine, P.le S. Maria della Misericordia, 15, Udine, UD 33100, Italy. Electronic address: c.tascini@gmail.com.
Marco AnselminoBariatric and Metabolic Surgery Unit, Azienda Ospedaliera at University of Pisa, Via Roma, 67, Pisa, PI 56126, Italy. Electronic address: m.anselmino@me.com.
Emanuela BianciardiDepartment of Bariatric and Metabolic Surgery, San Carlo of Nancy Hospital and "Tor Vergata" University of Rome, Via Aurelia 275, Roma, RM 00165, Italy.
Michela CampanelliDepartment of Bariatric and Metabolic Surgery, San Carlo of Nancy Hospital and "Tor Vergata" University of Rome, Via Aurelia 275, Roma, RM 00165, Italy.
Luigi FiorelloBariatric Surgery Unit, Azienda Ospedaliera of University of Padova, Via Nicolò Giustiniani 2, Padova, PD 35128, Italy.
Rudj ManciniBariatric and Metabolic Surgery Unit, Azienda Ospedaliera at University of Pisa, Via Roma, 67, Pisa, PI 56126, Italy.
Alberto OldaniDepartment of General and Oncological Surgery, Center of Bariatric Surgery, Policlinico San Marco di Zingonia, Bergamo Corso Europa 7, Zingonia, BG 24040, Italy.
Matteo RottoliMetabolic and Obesity Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Centre for the Study and Research of Treatment for Morbid Obesity, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Via Giuseppe Massarenti 9, Bologna, BO 40138, Italy.
Antonio SalzanoGeneral Surgery, Department of Surgical Sciences, University of Turin, Via Corso Bramante 88, Turin, TO 10126, Italy.
Manuela TrottaBariatric Unit, Humanitas Clinical and Research Hospital, IRCCS Rozzano, Milan Via A. Manzoni 56, Rozzano, MI 20089, Italy.
cooperative RESTART group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSars-Cov-2 epidemic in Italy caused one of the greatest 2020 European outbreaks, with suspension of elective bariatric/metabolic surgery (BMS). From May 2020 a significant decline of the epidemic has been observed (phase 2); National Health Service protocols permitted elective BMS' resumption. A new, more severe COVID-19 surge, the "second wave", started on October 2020 (phase 3).

aimThe primary end point was to analyze the outcomes of any Sars-Cov-2 infection and related morbidity/mortality within 30 POD after laparoscopic BMS during phase 2-3; secondary end points were readmission and reoperation rates.

methodsStudy design prospective, multicenter, observational.

settingEight Italian high-volume bariatric centers. All patients undergoing BMS from July 2020 through January 2021 were enrolled according to the following criteria: no Sars-Cov-2 infection; primary procedures; no concomitant procedure; age > 18 < 60 years; compensated comorbidities; informed consent including COVID-19 addendum; adherence to specific admission, in-hospital and follow-up protocols. Data were collected in a prospective database. Patients undergone BMS during July-December 2019 were considered a control group.

results1258 patients were enrolled and compared with 1451 operated on in 2019, with no differences for demographics, complications, readmission, and reintervention rates. Eight patients (0·6%) tested positive for Sars-Cov-2 infection after discharge, as well as and 15 healthcare professionals, with no related complications or mortality.

conclusionsIntroduction of strict COVID-19 protocols concerning the protection of patients and health-care professionals guaranteed a safe resumption of elective BMS in Italy. The safety profile was, also, maintained during the second wave of outbreak, thus allowing access to a cure for the obese population.

Indexed as

Bariatric SurgeryCOVID-19LaparoscopyAdultFemaleHumansItalyMaleMiddle AgedPandemicsPatient SafetyProspective StudiesState MedicineBariatric/metabolic surgeryGuidelinesPhase 2·3 COVID-19 pandemicProtocolsSafetySars-Cov-2 infection

Identifiers

PMID34133962
PMCPMC8200253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.